Skip to main content
CUMBERLAND PHARMACEUTICALS INC logo

CUMBERLAND PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · CPIX ISIN · US2307701092 US Manufacturing
Filings indexed 1,019 across all filing types
Latest filing 2026-04-24 Regulatory Filings
Country US United States of America
Listing US CPIX

About CUMBERLAND PHARMACEUTICALS INC

https://www.cumberlandpharma.com/

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company that acquires, develops, and commercializes a portfolio of branded, FDA-approved prescription products. The company focuses on delivering high-quality medicines designed to support medical professionals and patients, particularly in hospital and acute care settings. Its product portfolio includes Acetadote®, an injectable treatment for acetaminophen poisoning, and Caldolor®, an injectable non-steroidal anti-inflammatory drug. The company's mission is to improve the quality of patient care by providing innovative medical solutions.

Recent filings

Filing Released Lang Actions
8-K - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Filer)
Regulatory Filings
2026-04-24 English
8-K - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Filer)
Regulatory Filings
2026-04-23 English
4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
Director's Dealing
2026-03-20 English
4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
Director's Dealing
2026-03-20 English
4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
Director's Dealing
2026-03-20 English
4 - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Issuer)
Director's Dealing
2026-03-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.